Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02606994Phase 2Terminated
Phase 2, randomised, open-label trial in oral mucositis (OM) (2 arms). Primary endpoint: Oral mucositis changes at Day 8. Started May 2018; status: terminated.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02606994.